Tralokinumab for moderate-to-severe atopic dermatitis patients: first daily practice results.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad038
Abstract: BACKGROUND Evidence on tralokinumab treatment for moderate-to-severe atopic dermatitis (AD) in daily practice is limited. OBJECTIVES To report first experience with tralokinumab treatment in daily practice in AD patients. METHODS In this observational prospective study,… read more here.
Keywords: severe atopic; daily practice; moderate severe; tralokinumab treatment ... See more keywords
Review of Tralokinumab in the Treatment of Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221105686
Abstract: Objective To review pharmacokinetics, efficacy, and safety of tralokinumab in treatment of atopic dermatitis (AD). Data Sources Literature review was conducted using MEDLINE (PubMed), EMBASE, and ClinicalTrials.gov for articles published between January 2010 and May… read more here.
Keywords: tralokinumab; review; treatment atopic; atopic dermatitis ... See more keywords